Brief: 10X Genomics Q1 Revenue USD 141 Million Vs. IBES Estimate USD 142.2 Million
30/04/2024 21:05
Apr 30 (Reuters) - 10X Genomics Q1 net income USD -59.9 million vs. IBES estimate USD -60.5 million. * Q1 operating income USD -61.5 million vs. IBES estimate USD -59.9 million * Q1 gross margin 66%
Recent news on 10x Genomics
See all newsBrief: 10X Genomics Announces New Collaboration To Advance Single Cell And Spatial Applications Across Solid Tumors And Blood Cancers
U.S. RESEARCH ROUNDUP-Autodesk, Hubspot, Oracle
Delaware jury finds Parse infringed three genetic-sequencing patents (updated)
Qiagen owes 10x, Roche $4.8 million for infringing patents, U.S. jury says
Brief: 10X Genomics Wins Patent Infringement Verdict Against Parse Biosciences